Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Eur J Vasc Endovasc Surg. 2014 Sep;48(3):316-24. doi: 10.1016/j.ejvs.2014.05.019. Epub 2014 Jun 26.
To evaluate the outcomes of surgical revascularization for critical limb ischemia in patients with end-stage renal disease (ESRD).
From 2004 to 2010, 184 patients with 213 critically ischaemic limbs caused by arteriosclerosis were admitted to The University of Tokyo Hospital. The outcomes of primarily surgical revascularization-based treatments were retrospectively compared in patients with ESRD (ESRD group: 79 patients, 101 limbs) and without ESRD (non-ESRD group: 105 patients, 112 limbs) during the same period.
Arterial reconstruction was performed on 56 limbs in 46 patients in the ESRD group and 78 limbs in 73 patients in the non-ESRD group (55% vs. 70%; p = .03). Major amputation was performed in 6 of 48 limbs with patent grafts in the ESRD group because of uncontrolled infection or progression of necrosis. The limb salvage rate after arterial reconstruction was significantly lower in the ESRD group than in the non-ESRD group (p = .0019). The postoperative survival rate was lower in the ESRD group than in the non-ESRD group, although this difference was not significant (p = .052). Associated cardiovascular disease and systemic infection were the most frequent causes of death in the ESRD group. There was no significant difference in graft patency between the two groups after distal bypass surgery; however, the limb salvage rate was significantly lower in the ESRD group than in the non-ESRD group (p = .03).
Critical limb ischemia associated with ESRD has a poor prognosis. Infection control is particularly important for achievement of good treatment outcomes.
评估终末期肾病(ESRD)患者发生严重肢体缺血时进行外科血运重建的效果。
2004 年至 2010 年,184 名因动脉硬化导致 213 条严重肢体缺血的患者入住东京大学医院。在此期间,回顾性比较了同期 ESRD 患者(ESRD 组:79 名患者,101 条肢体)和非 ESRD 患者(非 ESRD 组:105 名患者,112 条肢体)主要采用外科血运重建治疗的效果。
在 ESRD 组中,46 名患者的 56 条肢体进行了动脉重建,而非 ESRD 组中 73 名患者的 78 条肢体进行了该手术(55%比 70%;p=0.03)。在 ESRD 组中,6 名患者的 48 条有通畅移植物的肢体因无法控制的感染或坏死进展而进行了大截肢。与非 ESRD 组相比,ESRD 组动脉重建后的肢体存活率明显较低(p=0.0019)。尽管两组间的术后生存率差异无统计学意义(p=0.052),但 ESRD 组的生存率低于非 ESRD 组。与 ESRD 组相关的心血管疾病和全身感染是导致死亡的最常见原因。在远端旁路手术后,两组间的移植物通畅率无显著差异;但与非 ESRD 组相比,ESRD 组的肢体存活率明显较低(p=0.03)。
与 ESRD 相关的严重肢体缺血预后较差。感染控制对获得良好的治疗效果尤为重要。